Regulation of Proto-Oncogene Expression in Adult and Developing Lungs

REFERENCES

• Alwine, J. C., D. J. Kemp, and G. R. Stark. 1977. Methods for detection of specific RNAs in agarose gels by transfer to diazobenzylo-methyl-paper and hybridization with DNA probes. Proc. Natl. Acad. Sci. USA 74:5350–5354.
   PubMed Web of Science ®Google Scholar
• Bartel, D. P., M. Sheng, L. F. Lau, and M. Greenberg. 1989. Growth factors and membrane depolarization activate distinct programs of early response gene expression-dissociation of fos and jun induction. Genes Dev. 3:304–313.
   PubMed Web of Science ®Google Scholar
• Curran, T., and B. R. Franza, Jr. 1988. Fos and Jun: the AP-1 connection. Cell 55:395–397.
   PubMed Web of Science ®Google Scholar
• Curran, T., and J. I. Morgan. 1987. Memories of fos. BioEssays 7:255–258.
   PubMedGoogle Scholar
• Diamond, M. I., J. N. Miner, S. K. Yoshinaga, and K. R. Yamamoto. 1990. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266–1272.
   PubMed Web of Science ®Google Scholar
• Garrison, J. C. 1990. Histamine, bradykinin, 5-hydroxy- tryptamine, and their antagonists, p. 575–579. In A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor (ed.), The pharmacological basis of therapeutics, 8th ed. Pergamon Press, New York.
   Google Scholar
• Jacobson, L., F. R. Sharp, and M. F. Dallman. 1990. Induction of Fos-like immunoreactivity in hypothalamic CRF neurons after adrenalectomy. Endocrinology 126:1709–1719.
   PubMedGoogle Scholar
• Konig, H., H. Ponta, H. J. Rahmsdorf, and P. Herrlich. 1992. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11:2241–2246.
   PubMed Web of Science ®Google Scholar
• Lau, L. F., and D. Nathans. 1987. Expression of a set of growth-related immediate-early genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J. 4:3145–3151.
   Google Scholar
• Morgan, J. I., D. R. Cohen, J. L. Hempstead, and T. Curran. 1987. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237:192–197.
   PubMed Web of Science ®Google Scholar
• Morgan, J. L, and T. Curran. 1991. Proto-oncogene transcription factors and epilepsy. Trends Pharmacol. Sci. 12:343–349.
   PubMed Web of Science ®Google Scholar
• Morgan, J. L, and T. Curran. 1991. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:421–451.
   Google Scholar
• Oberdick, J., R. J. Smeyne, J. R. Mann, S. Zackson, and J. I. Morgan. 1990. A promoter that drives transgene expression in cerebellar Purkinje and retinal bipolar neurons. Science 248:223–226.
   PubMedGoogle Scholar
• Pertovaara, L., L. Sistonen, T. J. Bos, P. K. Vogt, J. Keski-Oja, and K. Alitalo. 1989. Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol. Cell. Biol. 9:1255–1262.
   PubMed Web of Science ®Google Scholar
• Piper, P. J. 1984. Formation and actions of leukotrienes. Physiol. Rev. 64:744–761.
   PubMed Web of Science ®Google Scholar
• Rauscher, F. J.III, P. J. Voulalas, B. R. FranzaJr., and T. Curran. 1988. Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev. 2:1687–1699.
   PubMedGoogle Scholar
• Ryder, K., L. F. Lau, and D. Nathans. 1988. A gene activated by growth factors is related to the oncogene v-jun.. Proc.Natl. Acad. Sci. USA 85:1487–1491.
   PubMed Web of Science ®Google Scholar
• Sakai, M., A. Okuda, I. Hatayama, K. Sato, S. Mishi, and M. Muramatsu. 1989. Structure and expression of the rat c-jun messenger RNA: tissue distribution and increase during chemical hepatocarcinogenesis. Cancer Res. 49:5633–5637.
   PubMed Web of Science ®Google Scholar
• Schilling, K., D. Luk, J. I. Morgan, and T. Curran. 1991. Regulation of a fos-lacZ fusion gene: a paradigm for quantitative analysis of stimulus transcription coupling. Proc. Natl. Acad. Sci. USA 88:5665–5669.
   PubMedGoogle Scholar
• Smeyne, R. J., T. Curran, and J. I. Morgan. 1992. Temporal and spatial expression of a fos-lacZ transgene in the developing nervous system. Mol. Brain Res. 16:158–162.
   PubMedGoogle Scholar
• Smeyne, R. J., K. Schilling, L. Robertson, D. Luk, J. Oberdick, T. Curran, and J. I. Morgan. 1992. Fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron 8:13–23.
   PubMed Web of Science ®Google Scholar
• Smeyne, R. J., M. Vendrell, M. Hayward, S. J. Baker, G. G. Miao, K. Schilling, L. M. Robertson, T. Curran, and J. I. Morgan. Continuous c-fos expression precedes programmed cell death in vivo. Nature (London), in press.
   Google Scholar
• Sonnenberg, J. L., P. F. Macgregor-Leon, T. Curran, and J. I. Morgan. 1989. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron 3:359–365.
   PubMedGoogle Scholar
• Sonnenberg, J. L., C. Mitchelmore, P. F. Macgregor-Leon, J. Hempstead, J. I. Morgan, and T. Curran. 1989. Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in the mammalian brain. J. Neurosci. Res. 24:72–80.
   PubMed Web of Science ®Google Scholar
• Sonnenberg, J. L., F. J. RauscherIII, J. I. Morgan, and T. Curran. 1989. Regulation of proenkephalin by proto-oncogenes fos and jun. Science 246:1622–1625.
   PubMed Web of Science ®Google Scholar
• Strang, L. B. 1977. Growth and development of the lung: fetal and postnatal. Annu. Rev. Physiol. 39:253–276.
   PubMed Web of Science ®Google Scholar